DE69616367T2 - Kombinationstherapie für fortgeschrittenes krebsstadium mit temozolomid und cisplatin - Google Patents

Kombinationstherapie für fortgeschrittenes krebsstadium mit temozolomid und cisplatin

Info

Publication number
DE69616367T2
DE69616367T2 DE69616367T DE69616367T DE69616367T2 DE 69616367 T2 DE69616367 T2 DE 69616367T2 DE 69616367 T DE69616367 T DE 69616367T DE 69616367 T DE69616367 T DE 69616367T DE 69616367 T2 DE69616367 T2 DE 69616367T2
Authority
DE
Germany
Prior art keywords
temozolomide
cisplatin
cancer
combination therapy
advanced stage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69616367T
Other languages
English (en)
Other versions
DE69616367D1 (de
Inventor
H Dugan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69616367D1 publication Critical patent/DE69616367D1/de
Publication of DE69616367T2 publication Critical patent/DE69616367T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69616367T 1995-08-28 1996-08-26 Kombinationstherapie für fortgeschrittenes krebsstadium mit temozolomid und cisplatin Expired - Lifetime DE69616367T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US287795P 1995-08-28 1995-08-28
US62479596A 1996-03-27 1996-03-27
PCT/US1996/013479 WO1997007804A1 (en) 1995-08-28 1996-08-26 Combination therapy for advanced cancer comprising temozolomide and cisplatin

Publications (2)

Publication Number Publication Date
DE69616367D1 DE69616367D1 (de) 2001-11-29
DE69616367T2 true DE69616367T2 (de) 2002-06-27

Family

ID=26670993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616367T Expired - Lifetime DE69616367T2 (de) 1995-08-28 1996-08-26 Kombinationstherapie für fortgeschrittenes krebsstadium mit temozolomid und cisplatin

Country Status (11)

Country Link
EP (1) EP0858341B1 (de)
JP (1) JPH10511108A (de)
AT (1) ATE207359T1 (de)
AU (1) AU6955396A (de)
CA (1) CA2229141A1 (de)
DE (1) DE69616367T2 (de)
DK (1) DK0858341T3 (de)
ES (1) ES2162092T3 (de)
GR (1) GR3037047T3 (de)
PT (1) PT858341E (de)
WO (1) WO1997007804A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE330600T1 (de) * 2000-01-26 2006-07-15 Schering Corp Kombinationspräparat zur krebstherapie
US20070265324A1 (en) * 2006-01-17 2007-11-15 Wolfgang Wernet Combination Therapy with Parp Inhibitors
EP2004148B1 (de) 2006-04-05 2015-07-15 OPKO Health, Inc. Salze von (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-on beinhaltende pharmazeutische Formulierungen und deren medizinische Verwendung
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
EP2379080A1 (de) * 2009-01-13 2011-10-26 ProteoSys AG Pirenzepin als otoprotektives mittel
CA3164592A1 (en) * 2020-01-13 2021-07-22 Luis Alberto Diaz Methods and compositions for cancer immunotherapy

Also Published As

Publication number Publication date
DK0858341T3 (da) 2001-11-19
AU6955396A (en) 1997-03-19
EP0858341A1 (de) 1998-08-19
GR3037047T3 (en) 2002-01-31
MX9801585A (es) 1998-05-31
WO1997007804A1 (en) 1997-03-06
DE69616367D1 (de) 2001-11-29
PT858341E (pt) 2002-03-28
CA2229141A1 (en) 1997-03-06
EP0858341B1 (de) 2001-10-24
ATE207359T1 (de) 2001-11-15
JPH10511108A (ja) 1998-10-27
ES2162092T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
PT880350E (pt) Tratamento de esclerose multipla
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
DE69737066D1 (de) Verwendung von activem vitamin d analoga zur behandlung von prostataerkrangkungen
MY113059A (en) Controlled-release dosage forms of azithromycin
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
FI971290A (fi) Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
CY1105564T1 (el) Θεραπεια συνδυασμου για καρκινο
DE69616367D1 (de) Kombinationstherapie für fortgeschrittenes krebsstadium mit temozolomid und cisplatin
PT859630E (pt) Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DE69821970D1 (de) Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
NO984198L (no) FremgangsmÕte for behandling av aggresjon
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
SU1823193A1 (ru) Способ лечения рака гортани
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
WO2000033823A3 (en) Methods of using temozolomide in the treatment of cancers
RU94025702A (ru) Способ лечения хронической венозной недостаточности нижних конечностей у больных остеоартрозом
UA23985A (uk) Спосіб лікуваhhя запальhих захворюваhь вhутрішhіх геhіталій у дівчат та підлітків
RU94020918A (ru) Способ лечения опсоменореи
UA30257A (uk) Спосіб нормалізації тканинного обміну та відновлення морфофункціонального стану органів і тканин
ES8705241A2 (es) Procedimiento de terapia por campos magneticos con multipli-cidad de tipos de onda y control de solenoide bajo procesa- dor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition